Viewing StudyNCT00137969



Ignite Creation Date: 2024-05-05 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00137969
Status: COMPLETED
Last Update Posted: 2019-08-20
First Post: 2005-08-26

Brief Title: A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus
Sponsor: Genentech Inc
Organization: Genentech Inc

Conditions & Keywords Data

Conditions:
Name
Lupus Erythematosus Systemic
Keywords:
Name View
Lupus View
Rituxan View
SLE View